as on February 4, 2026 at 2:29 am IST
Day's Low
Day's High
5.17%
Downside
6.03%
Upside
52 Week's Low
52 Week's High
43.01%
Downside
67.23%
Upside
Check Fate Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$141.9M
EPS (TTM)
-1.1489
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.29
Industry PE ratio
-1.9307053941908714
PEG Ratio
0EBITDA
-145.3M
Revenue (TTM)
7.1M
Profit Margin
0.00%
Return On Equity TTM
-52.35%
Track how Fate Therapeutics Inc P/E has moved over time to understand its valuation trends.
Fate Therapeutics Inc in the last 5 years
Lowest (-45.20x)
March 31, 2021
Today (-2.29x)
February 4, 2026
Industry (-1.93x)
February 4, 2026
Highest (-0.80x)
June 30, 2025
Today’s Price to Earnings Ratio: -2.29x
Compare market cap, revenue, PE, and other key metrics of Fate Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $141.9M | -98.87% | -2.29 | 0.00% | |
| BUY | $122.3B | 117.87% | 33.56 | 31.35% | |
| BUY | $47.7B | 122.79% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.19% | 18.28 | 32.13% |
The Fate Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Fate Therapeutics Inc investment value today
Current value as on today
₹92,287
Returns
Returns from Fate Therapeutics Inc Stock
Dollar Returns*
₹3,737 (+3.74%)
Based on 26 analysts
42.31%
Buy
53.85%
Hold
3.85%
Sell
Based on 26 analysts, 53.85% of analysts recommend a 'HOLD' rating for Fate Therapeutics Inc. Average target price of $4.94
Get share price movements and forecasts by analysts on Fate Therapeutics Inc.
What analysts predicted
76.52%UPSIDE
Target Price
$4.94
Current Price
$1.16
Analyzed by
26 Analysts
Target
$4.94
Fate Therapeutics Inc target price $4.94, a slight upside of 76.52% compared to current price of $1.16. According to 26 analysts rating.
Search interest for Fate Therapeutics Inc Stock has increased by 105% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:105% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, FATE stock has moved up by 24.7%
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -52.15M → -32.25M (in $), with an average increase of 18.2% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 54.8% return, outperforming this stock by 60.9%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 34.3% return, outperforming this stock by 116.4%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.90M → 1.74M (in $), with an average decrease of 8.7% per quarter
| Organisation | Fate Therapeutics Inc |
| Headquarters | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
| Industry | Health Technology |
| CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Jessica Francis | Vice President Of Human Resources & Operations |
Mr. Andrew Henry | Senior Vice President of Clinical Operations |
Dr. Tunde Babalola Ph.D. | Senior Vice President of Technical Operations |
Dr. Yu Cai J.D., Ph.D. | Head of Intellectual Property & Assistant General Counsel |
Ms. Kate Duvall | Corporate Controller |
Dr. Bahram Valamehr M.B.A., Ph.D. | President, CEO & Director |
Ms. Cindy R. Tahl J.D. | Chief Legal & Compliance Officer and Corporate Secretary |
Mr. Kamal Adawi M.S., MBA | Chief Financial Officer |
Fate Therapeutics Inc share price today is $1.16 as on at the close of the market. Fate Therapeutics Inc share today touched a day high of $1.23 and a low of $1.1.
Fate Therapeutics Inc share touched a 52 week high of $1.94 on and a 52 week low of $0.66 on . Fate Therapeutics Inc stock price today i.e. is closed at $1.16,which is 40.20% down from its 52 week high and 75.48% up from its 52 week low.
Fate Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Fate Therapeutics Inc (FATE) shares with as little as ₹90.22 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.20 in Fate Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Fate Therapeutics Inc share’s latest price of $1.16 as on February 4, 2026 at 2:29 am IST, you will get 8.6207 shares of Fate Therapeutics Inc. Learn more about
fractional shares .
Fate Therapeutics Inc stock has given -98.87% share price returns and 25.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?